New program aims to bridge support gap for black and latina women with advanced breast cancer

NCT ID NCT06405828

Recruiting now Symptom relief Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests a program called ACCESS, where a community navigator helps Black and Latina women with metastatic breast cancer connect to supportive care and community resources. Participants receive six coaching sessions and monthly check-ins over 16 weeks. The goal is to see if this approach is feasible and acceptable, and whether it reduces distress and symptom burden.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Community navigator-led supportive care program (coaching sessions, monthly check-ins, resource linkage)
What this could lead to: If successful, this could show that a navigator-based program improves access to supportive services and reduces distress for underserved women with advanced breast cancer.
What could go wrong: This is a small pilot study (67 participants) focused on feasibility, not effectiveness. It may not prove the program improves health outcomes, and results may not apply to other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC BREAST CANCER STAGE IV BREAST CANCER AJCC V7

Contacts and locations

Locations

Mount Sinai Hospital
RECRUITING

New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.